Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002486066 | SCV002792360 | uncertain significance | Retinitis pigmentosa; Retinitis pigmentosa 61; Usher syndrome type 3A | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002542940 | SCV003487004 | uncertain significance | not provided | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 136 of the CLRN1 protein (p.Gly136Arg). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with CLRN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 991769). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001280037 | SCV001467183 | uncertain significance | Usher syndrome type 3A | 2020-08-14 | no assertion criteria provided | clinical testing |